Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress
On the opening day, the organizers unveiled the winners of the 2025 World Dairy Innovation Awards. Yili secured four World Dairy Innovation Awards and six commended Awards. Notably, Yili has claimed the World Dairy Innovation Awards for six consecutive years.
Dr. Carolien van Loo , Head of Yili Innovation Center Europe, attended a roundtable forum on maternal and infant nutrition and breast milk research. Multiple star products from Yili's top infant formula brand, Pro-Kido, were featured as the Congress's officially designated products.
At the Industry Leadership Forum, Dr. Ignatius Szeto systematically introduced Yili's global innovation practices across product innovation, maternal and infant nutrition, advanced dairy processing, and sustainable development. He emphasized: "Innovation is the driving force behind the sustainable prosperity of the dairy industry. Remaining consumer-centric, Yili dedicates itself to nutrition and health research across the full life cycle, keeps making core technological breakthroughs, and accelerates the commercialization of fundamental research outcomes—all of which contribute to the advancement of the global dairy sector."
During the roundtable forum themed "Innovation in Pioneering a New Future for Global Maternal and Infant Health", Dr. Ignatius Szeto and Dr. Carolien van Loo engaged in in-depth discussions with experts including Jean-Christophe Kremer , Secretary-General of the International Special Dietary Foods Industries, and Richard Hall , Chair of FoodBev Media. The discussions focused on research about breast milk and maternal and infant nutrition. Dr. Carolien van Loo highlighted that Yili Innovation Center Europe, in collaboration with institutions such as Wageningen University and Donders Institute for Brain, Cognition and Behaviour, has conducted pioneering research on HMOs. Their breakthrough findings demonstrated HMOs' health benefits in enhancing immunity, protecting gut barrier function, preventing pathogen adhesion, and promoting cognitive development.
The annual World Dairy Innovation Awards were announced at the event. This year, Yili Group secured four awards for its high-quality products and outstanding performance in innovation. Zhenlao Light Cream from Yijiahao Cheese won the Best Artisan Product, Joyday Crunchy Choco Lava was awarded Best Ice Cream, Yili's patented multi-enzymatic lactose-to-GOS technology: Boosting Gut Health in Qinghuo Adult Milk Powder claimed the Best Intolerance-Friendly Innovation, and Satine Carbon-Reduced Organic Milk won the Best CSR/Sustainability Initiative.
Staying true to its philosophy of "No Innovation, No Future," Yili consistently increases its R&D investment to provide comprehensive nutrition solutions for consumers across the full life cycle. To date, Yili has established 15 innovation centers across Asia , Europe , and Oceania.
Moving forward, Yili will continue to align its strategy with consumer needs, drive growth through technological innovation, and foster global partnerships to deliver enhanced health value for consumers worldwide, aiming to enable the sustainable prosperity of the dairy industry.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
1 Stock Down 40% This Year to Buy and Hold
Key Points Novo Nordisk's shares have been trending downward due to clinical setbacks and underwhelming results. However, the company has some potential catalysts on the way that could jolt its stock price. Novo Nordisk looks attractive given its lineup and pipeline, especially at current levels. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market. However, the Denmark-based drugmaker has given up most of these gains over the past year; the stock is down by 40% since January alone. Despite its recent misfortunes, Novo Nordisk's shares could still deliver strong returns to patient investors. Here's why. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » NVO Total Return Level data by YCharts. The weight management opportunity Novo Nordisk primarily develops medicines for diabetes and, in recent years, weight management. Its stock has plunged over the past year because its financial results haven't been as impressive as the market had hoped. It also faced some clinical setbacks, while its biggest rival in its core markets, Eli Lilly, earned some important wins. However, there's more to the story. The market for anti-obesity medications could grow at an incredibly rapid rate. Some analysts estimate that it will be worth $150 billion by 2035, compared to $15 billion last year. Novo Nordisk still has one of the deepest pipelines in the industry. In fact, it's challenging to find a company other than Eli Lilly that has more promising products. Recently, Novo Nordisk expanded its pipeline through various licensing deals. Here's one more thing that recently broke its way: Eli Lilly's oral GLP-1 candidate, orforglipron, did not perform nearly as well as expected in a phase 3 study. This opens the door for Novo Nordisk to catch up to its longtime rival. The company's oral version of Wegovy is currently awaiting approval from regulators in the U.S. The oral version led to an average weight reduction of 13.6% in a phase 3 clinical trial, slightly higher than the 12.4% that orforglipron recently posted in its late-stage study. While it's always hard to compare across clinical trials, the data at the very least suggests that oral Wegovy is comparable to orforglipron -- but only the former drug is closing in on approval. Novo Nordisk also has yet another promising anti-obesity candidate in phase 3 studies, amycretin, which the Denmark-based pharmaceutical giant is testing in both subcutaneous and oral formulations. Why is the race to develop an oral weight loss option so important? Pills are easier and cheaper to manufacture, store, and transport. So, compared to injectable weight loss therapies, oral versions would allow drugmakers to produce them more cost-effectively and to expand the reach of weight loss therapies. On top of that, some patients are strongly averse to needles. Because the current leading weight management drugs are administered subcutaneously, an oral option would likely take a decent share of the market. Novo Nordisk is likely to be first to market. And the company could follow up that win with another oral product in amycretin. The price is right Let's go back to Novo Nordisk's recent and disappointing financial results. In the first half of the year, revenue rose by 16% year over year to 154.9 billion Danish kroner ($24.2 billion), while net profit came in at 55.5 billion DKK ($8.7 billion). Perhaps that's not quite what the market expected to see, but these are still excellent results for a pharmaceutical giant -- most drugmakers of that size would be happy to grow their revenue at high-single-digit or low-double-digit rates. Meanwhile, the stock appears reasonably valued, trading at 13 times forward earnings, compared to the healthcare industry 's average of 16.2. What's the verdict? Novo Nordisk looks attractive at current levels, given the company's strong pipeline in weight management and a lineup that continues to deliver consistent profits. Despite recent setbacks, the stock is well-positioned to deliver excellent results over the long term. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025
CTV News
20 hours ago
- CTV News
Thrift stores team up to highlight work as an ‘essential lifeline'
Bissell, Trust FIND and Mustard Seed Thrift partnered up to create an all-day event that showcases the importance of thrift stores on Aug. 16, 2025. (Brandon Lynch/CTV News Edmonton) Three thrift stores in the city have partnered to create a tour that aims to show customers just how far the sustainability effort really goes. In honour of National Thrift Shop Day on Sunday, Bissell Thrift Shop, Trust FIND and The Mustard Seed have created a Saturday event for a YEG venture that helps fund local programs to end homelessness and poverty while keeping usable goods out of landfills. 'There are shops that are taking the funds being raised and putting them back into programs,' communications specialist Chris Schieman for Bissell told CTV News on Saturday. 'They're an essential lifeline to all that we do for our community.' Schieman said people from all walks of life come through thrift stores on a regular basis, which makes them so popular and worth celebrating. The collaboration of thrift stores was born out of wanting a 'bigger bang' during National Thrift Shop Day. Wendy Shea, a shopper at the event on Saturday, said both the cost of living and consumer-conscious spending are what drives her and her family out to thrift stores. 'We do a lot of back-to-school shopping at the thrift store,' she said. 'We like to support because we know that they do help the community and help house the homeless, and that's great. That's where we want to put our money.' The tour also includes a passport, where visiting the participating stores will enter participants into a draw to win prizes. Stamping even two of the three shops enters you to win a chocolate basket, restaurant or ice cream gift card. While the event ends on Saturday, other thrift stores around town will also be celebrating the day on Sunday. With files from CTV News Edmonton's Brandon Lynch
Globe and Mail
2 days ago
- Globe and Mail
Can AECOM's $24.6B Backlog Weather Economic and Policy Shocks?
AECOM 's ACM growth prospects are gaining from the robust public infrastructure spending environment, with several federal and state initiatives across the United States backing the wave. Given the company's expertise across diversified service offerings, it is successfully managing to capitalize on these opportunities and boost its revenue visibility in the process. Moreover, ACM prioritizing sustainability and innovation is resonating with the clients' priorities and global trends, further catalyzing the growth trends. However, amid all the favorable market trends, the company faces challenges due to macroeconomic uncertainties and potential project delays, especially across government projects. What's Driving AECOM's Momentum? Global Public Spending Trends: AECOM has been witnessing robust market trends due to the $1.2 trillion Infrastructure Investment and Jobs Act (IIJA) in the United States, with public infrastructure demand reaching new heights. Recently, the company highlighted that since the launch, only about 36% of the IIJA funding has been spent across its target markets. This positioning reflects incremental long-term revenue visibility for it mainly across key market segments, including AI (with data centers taking the major share), water, transportation, aviation, coastal protection and electricity. These favorable trends are also being shared by a few key market players, including Jacobs Solutions Inc. J, EMCOR Group, Inc. EME and Quanta Services, Inc. PWR, offering substantial competition to AECOM, especially across data center projects. Similar public spending trends are now visible in AECOM's international markets, including the United Kingdom, Canada, the UAE and Asia. The recent 10-year infrastructure strategy announcement by the U.K. government highlights investments of GBP 725 billion across key sectors, including transportation, water and energy, reflecting heightened opportunities for the company in the upcoming term. In the Middle East, AECOM successfully managed to align its opportunities with the shifts in investment priorities for infrastructure development for the World Expo and World Cup in Saudi Arabia. With Canada's aim of prioritizing public infrastructure projects 60% quicker, the company is positioned to capitalize on these tailwinds in the near and long term. Favorable Long-Term Growth Positioning: Thanks to the robust initiation of government strategies regarding the enhancement of public infrastructure, alongside AECOM's in-house capabilities, the company's backlog is growing, in turn, increasing revenue visibility in the upcoming period. As of the third quarter of fiscal 2025, the total backlog was $24.59 billion, up 5% from $23.36 billion reported in the prior-year period. Moreover, during the first nine months of fiscal 2025, NSR grew 6% on an adjusted basis to $1.938 billion, with net service revenues (defined as revenues excluding subcontractor and other direct costs) in the Americas and International segments growing year over year by 8% and 3%, respectively. The company's investment strategies to enhance leadership, technical development and AI capabilities offer its substantial competitive advantage over its market peers, underpinning its ability to consistently secure large and complex projects, as indicated in its top rankings by Engineering News-Record across major markets. For the long term, AECOM aims to achieve 5-8% organic NSR growth annually, with at least 20-30 basis points of adjusted operating margin and adjusted EBITDA margin expansion. Focus on Sustainability & Innovation: AECOM's investments in digital water systems, predictive analytics and energy-efficient infrastructure position it as a forward-thinking leader. The adoption of digital water solutions is addressing a $70 billion market opportunity through 2030, particularly in regions like the United States and the United Kingdom, where water utilities are undergoing modernization. Thanks to its innovative approach regarding sustainability, the company was recently selected by a major U.S. water client for a significant metering project, indicating the growing demand for accurate water management. Through a combination of strong market trends, strategic focus and operational excellence, AECOM is poised to capitalize on long-term growth drivers while maintaining its leadership in the global infrastructure space. Risks to AECOM's Growth Lingering Macro Risks: AECOM operates across multiple geographies. Factors like changes in the United States' and other national governments' trade policies, regulatory practices, tariffs and taxes, further devaluations and other conversion restrictions and logistical & communication challenges might adversely impact the company's financials. The ongoing uncertainties surrounding the new tariff regime are hammering the nail, and are expected to dig in deeper in the upcoming period in the form of increased costs and expenses. In fiscal 2024, 27% of total revenues were attributable to the services provided to non-U.S. clients. The ongoing conflict between Russia and Ukraine, political and economic instability in the Middle East and Southeast Asia and currency fluctuations are posing as major threats to the company in the current environment. Project Delays: The company derives a considerable share of its revenues from government projects, exposing it more to the adverse impacts of alterations in the government rules and regulations. Moreover, the company's inability to renew government contracts during regulated procurement processes can materially impact operations and reduce profits & revenues going forward. During fiscal 2024, 2023 and 2022, approximately 46%, 43% and 41%, respectively, of its total revenues were derived from contracts with government entities. Given the long-term nature of most government contracts, any budgetary changes during the tenure are expected to negatively affect AECOM's business. Details on the Other Market Players Jacobs: This Texas-based provider of professional, technical and construction services is witnessing steady progress across key sectors, including Life Sciences, Data Center, Energy & Power, Water and Transportation. Jacobs has been witnessing strong growth in Water and Environmental services, driven by government-backed infrastructure projects, climate resilience initiatives and investments in aging infrastructure. At the fiscal third-quarter 2025 end, the backlog of $22.7 billion was up 14.3% on a year-over-year basis, with a book-to-bill ratio of 1.2x. EMCOR: This Connecticut-based mechanical and electrical construction, industrial and energy infrastructure, and building services provider is massively gaining from the growing infrastructural demand across the network and communications sector, mainly in data centers. As of June 30, 2025, Remaining Performance Obligations (RPOs) were $11.91 billion, indicating 22% organic growth and 32.4% growth after including Miller Electric's acquisition contribution, year over year. The diversity in EMCOR's RPOs stretches across various market segments, with the networking and communications sector contributing about $3.8 billion (as of June 30), and the healthcare sector contributing $1.4 billion. Quanta: This Texas-based infrastructure services provider's strength lies in its ability to deliver complex, large-scale projects such as power grid modernization, solar and wind farm buildouts and next-gen telecom networks. Moreover, the recent acquisition of Dynamic Systems (DSI), LLC, strengthens Quanta's critical path capabilities and front-end services for the growing technology, manufacturing and other load center markets. As of June 30, 2025, the company had a total backlog of $35.84 billion, with a 12-month backlog of $20.05 billion. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Quanta Services, Inc. (PWR): Free Stock Analysis Report AECOM (ACM): Free Stock Analysis Report EMCOR Group, Inc. (EME): Free Stock Analysis Report Jacobs Solutions Inc. (J): Free Stock Analysis Report
